Home > Share Market > Stocks > Panacea biotec > Financial Statements > PANACEABIO Key Financial Ratios

Panacea biotec Financial Statements

Panacea biotec Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 14.80 (8.20) 8.97 (17)
Op profit growth 144 (63) 35.40 (44)
EBIT growth 130 (48) (16) (30)
Net profit growth (24) 163 35.80 198
Profitability ratios (%)        
OPM 12.30 5.76 14.30 11.50
EBIT margin 6.56 3.28 5.81 7.55
Net profit margin (24) (36) (12) (10)
RoCE 4.61 1.41 2.26 2.56
RoNW 247 (19) (5.60) (3.40)
RoA (4.10) (3.80) (1.20) (0.80)
Per share ratios ()        
EPS (24) (32) -- --
Dividend per share -- -- -- --
Cash EPS (32) (39) (22) (20)
Book value per share (37) 32.50 50.40 58.10
Valuation ratios        
P/E (7.40) (3.20) -- --
P/CEPS (5.60) (2.60) (11) (7.40)
P/B (4.80) 3.10 4.86 2.54
EV/EBIDTA 20.40 21.70 27.50 18
Payout (%)        
Dividend payout -- -- -- --
Tax payout 1.36 10.70 14.90 (18)
Liquidity ratios        
Debtor days 44.70 68.60 85.60 95.20
Inventory days 94 162 200 208
Creditor days (140) (169) (189) (165)
Leverage ratios        
Interest coverage (0.20) (0.10) (0.30) (0.40)
Net debt / equity (3) 3.28 2.97 2.75
Net debt / op. profit 8.92 20.80 10.90 15.70
Cost breakup ()        
Material costs (33) (29) (32) (27)
Employee costs (25) (26) (26) (27)
Other costs (30) (39) (29) (34)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000